Eton Pharmaceuticals, Inc. ETON Increlex — Contract With Customer Liability Noncurrent
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s increlex — contract with customer liability noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s increlex — contract with customer liability noncurrent?
- Eton Pharmaceuticals, Inc. (ETON) reported increlex — contract with customer liability noncurrent of $1.76M in Q1 2026.
- What does increlex — contract with customer liability noncurrent mean?
- The portion of the total contract liability for Increlex that is expected to be satisfied or recognized as revenue beyond the next twelve months. This represents long-term obligations to customers that have been paid for in advance. It indicates the stability and duration of the company's long-term contractual relationships for this product.